AI Science Tracker
EN

College of Public Health, Zhengzhou University, Zhengzhou, China

1 discovery from 2022

Discoveries

Machine learning-assisted prediction of pneumonia based on non-invasive measures

Source check: Source checked. Not independent scientific confirmation.

Finding: A retrospective single-center cohort of 535 lower-respiratory-illness patients was classified as pneumonia versus bronchitis from non-invasive measures; the authors report cross-validated and held-out model performance. This is diagnostic evidence on the study sample, not prospective or clinical-utility validation.

Technology: Eight machine-learning classifiers distinguish pneumonia from bronchitis using clinical and laboratory measures.

Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.

AI contribution
Eight machine-learning classifiers distinguish pneumonia from bronchitis using clinical and laboratory measures.
Test and result
The paper reports experiments on 535 patients and performance metrics for RF/XGBoost on original and resampled data, with pneumonia/bronchitis as outcome classes.
Limitation / still unknown
The study reports five-fold cross-validation and an 80/20 training/test split on a retrospective single-center sample. This supports a bounded diagnostic-model result, but not generalization or clinical benefit.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://doi.org/10.3389/fpubh.2022.938801 · https://www.frontiersin.org/journals/public-health/articles/10.3389/fpubh.2022.938801/full · https://pubmed.ncbi.nlm.nih.gov/35968461/

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.

Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 2/5 · Validation 2/5 · Novelty 2/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open the interactive profile for the timeline, or browse all organizations and model families.